VINGRAF 0.25 CAPSULE contains Tacrolimus which belongs to the group of medicines called Immunosuppressants. It is used to manage graft rejection in patients undergoing organ transplantation. It can also be used to manage an ongoing graft rejection of the newly transplanted organ. It is mostly used in combination with other immune suppressants to achieve maximum benefits.
Tacrolimus suppresses your body’s immune functions and enables your body to accept the transplanted organ. Take VINGRAF 0.25 CAPSULE regularly as instructed by your doctor. While undergoing therapy with VINGRAF 0.25 CAPSULE your doctor will periodically monitor your heart functions and nerve functions to avoid the risk of side effects.
Your doctor may also prescribe you blood tests and urine tests at regular intervals to access the improvement in your health conditions. During management with VINGRAF 0.25 CAPSULE, avoid exposing your skin towards direct sunlight. Wear protective loose-fitting clothes and apply sunscreen while going outdoors.
Before taking VINGRAF 0.25 CAPSULE inform your doctor if you have any liver, kidney or heart problems. Avoid consuming grapefruit or drinking grapefruit juice while taking VINGRAF 0.25 CAPSULE as it may increase the risk of side effects.
Do not take VINGRAF 0.25 CAPSULE without consulting your doctor if you are pregnant or breastfeeding. Both men and women taking VINGRAF 0.25 CAPSULE must use a suitable contraceptive method (such as condoms or oral contraceptive pills) to avoid pregnancy while undergoing therapy with VINGRAF 0.25 CAPSULE.
The most common side effects of taking VINGRAF 0.25 CAPSULE are an increase in blood sugar levels, increased blood cholesterol levels, difficulty in falling asleep, increased blood potassium levels, high blood pressure, headache, dizziness, indigestion, oedema and increased infections. Consult your doctor if any of these side effects worsen.
No content available
